Drug information for KADIAN
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
CAPSULE, EXTENDED RELEASE; ORAL
100MG
Prescription
AB (Reference Drug)
MORPHINE SULFATE
Morphine
ACTAVIS ELIZABETH
20616
2011-02-04 Review
2007-11-19 Review
2007-11-19 Review
2007-05-01 Letter
2007-04-25 Label
2007-03-07 Letter
2007-03-07 Letter
2007-03-07 Label
2007-03-07 Label
2006-11-06 Label
2006-11-06 Letter
2005-10-20 Letter
2005-09-30 Label
CAPSULE, EXTENDED RELEASE; ORAL
10MG
Prescription
(Reference Drug)
MORPHINE SULFATE
Morphine
ACTAVIS ELIZABETH
"
CAPSULE, EXTENDED RELEASE; ORAL
200MG
Prescription
(Reference Drug)
MORPHINE SULFATE
Morphine
ACTAVIS ELIZABETH
"
CAPSULE, EXTENDED RELEASE; ORAL
20MG
Prescription
AB
MORPHINE SULFATE
Morphine
ACTAVIS ELIZABETH
"
CAPSULE, EXTENDED RELEASE; ORAL
30MG
Prescription
AB
MORPHINE SULFATE
Morphine
ACTAVIS ELIZABETH
"
CAPSULE, EXTENDED RELEASE; ORAL
50MG
Prescription
AB
MORPHINE SULFATE
Morphine
ACTAVIS ELIZABETH
"
CAPSULE, EXTENDED RELEASE; ORAL
60MG
Prescription
AB
MORPHINE SULFATE
Morphine
ACTAVIS ELIZABETH
"
CAPSULE, EXTENDED RELEASE; ORAL
80MG
Prescription
AB
MORPHINE SULFATE
Morphine
ACTAVIS ELIZABETH
"
Drug Adverse Effects information for KADIAN
Role code
Indications
Reaction
# Reports
SS
BLOOD CHOLESTEROL INCREASED
DIZZINESS
1
SS
BLOOD CHOLESTEROL INCREASED
NIGHT BLINDNESS
1
SS
BLOOD CHOLESTEROL INCREASED
VISION BLURRED
1
SS
BLOOD CHOLESTEROL INCREASED
VISUAL ACUITY REDUCED
1
SS
FIBROMYALGIA
DIZZINESS
1
SS
FIBROMYALGIA
NIGHT BLINDNESS
1
SS
FIBROMYALGIA
VISION BLURRED
1
SS
FIBROMYALGIA
VISUAL ACUITY REDUCED
1
SS
HYPERTENSION
DIZZINESS
1
SS
HYPERTENSION
NIGHT BLINDNESS
1
SS
HYPERTENSION
VISION BLURRED
1
SS
HYPERTENSION
VISUAL ACUITY REDUCED
1
SS
INTERVERTEBRAL DISC DEGENERATION
DIZZINESS
1
SS
INTERVERTEBRAL DISC DEGENERATION
NIGHT BLINDNESS
1
SS
INTERVERTEBRAL DISC DEGENERATION
VISION BLURRED
1
SS
INTERVERTEBRAL DISC DEGENERATION
VISUAL ACUITY REDUCED
1
SS
OSTEOPOROSIS
DIZZINESS
4
SS
OSTEOPOROSIS
NIGHT BLINDNESS
4
SS
OSTEOPOROSIS
VISION BLURRED
4
SS
OSTEOPOROSIS
VISUAL ACUITY REDUCED
4
SS
PAIN
DIZZINESS
1
SS
PAIN
HYPERTENSIVE HEART DISEASE
2
SS
PAIN
NIGHT BLINDNESS
1
SS
PAIN
TOXICITY TO VARIOUS AGENTS
2
SS
PAIN
VISION BLURRED
1
SS
PAIN
VISUAL ACUITY REDUCED
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
FACE OEDEMA
10
SS
SLEEP DISORDER
DIZZINESS
1
SS
SLEEP DISORDER
NIGHT BLINDNESS
1
SS
SLEEP DISORDER
VISION BLURRED
1
SS
SLEEP DISORDER
VISUAL ACUITY REDUCED
1
SS
THYROID DISORDER
DIZZINESS
1
SS
THYROID DISORDER
NIGHT BLINDNESS
1
SS
THYROID DISORDER
VISION BLURRED
1
SS
THYROID DISORDER
VISUAL ACUITY REDUCED
1
C
BACK PAIN
ABDOMINAL PAIN UPPER
1
C
BLADDER DISORDER
ARTHRALGIA
2
C
BLADDER DISORDER
NAUSEA
2
C
BLADDER DISORDER
VISUAL FIELD DEFECT
2
C
BLOOD CHOLESTEROL
DYSPEPSIA
1
C
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
ABDOMINAL PAIN UPPER
1
C
LUNG INFECTION
RASH
1
C
MULTIPLE MYELOMA
DECREASED APPETITE
2
C
MULTIPLE MYELOMA
ENTEROCOLITIS
2
C
MULTIPLE MYELOMA
ENTEROCOLITIS INFECTIOUS
2
C
MULTIPLE MYELOMA
INFECTION
2
C
MULTIPLE MYELOMA
NEUTROPENIA
2
C
MULTIPLE MYELOMA
PLATELET COUNT DECREASED
2
C
MULTIPLE MYELOMA
WHITE BLOOD CELL COUNT INCREASED
2
C
MULTIPLE SCLEROSIS
ARTHRALGIA
3
C
MULTIPLE SCLEROSIS
NAUSEA
3
C
MULTIPLE SCLEROSIS
VISUAL FIELD DEFECT
3
C
PAIN
ARTHRALGIA
1
C
PAIN
NAUSEA
1
C
PAIN
VISUAL FIELD DEFECT
1
C
PANCREATIC CARCINOMA
DEATH
1
C
PANCREATIC CARCINOMA
INCORRECT DOSE ADMINISTERED
1
C
PRODUCT USED FOR UNKNOWN INDICATION
DEATH
10
C
PRODUCT USED FOR UNKNOWN INDICATION
INCORRECT DOSE ADMINISTERED
10
C
PROPHYLAXIS
DECREASED APPETITE
7
C
PROPHYLAXIS
ENTEROCOLITIS
7
C
PROPHYLAXIS
ENTEROCOLITIS INFECTIOUS
7
C
PROPHYLAXIS
INFECTION
7
C
PROPHYLAXIS
NEUTROPENIA
7
C
PROPHYLAXIS
PLATELET COUNT DECREASED
7
C
PROPHYLAXIS
WHITE BLOOD CELL COUNT INCREASED
7
Ads by Google